Understanding Passive Membrane Permeation of Peptides: Physical Models and Sampling Methods Compared
Overview
Chemistry
Molecular Biology
Authors
Affiliations
The early characterization of drug membrane permeability is an important step in pharmaceutical developments to limit possible late failures in preclinical studies. This is particularly crucial for therapeutic peptides whose size generally prevents them from passively entering cells. However, a sequence-structure-dynamics-permeability relationship for peptides still needs further insight to help efficient therapeutic peptide design. In this perspective, we conducted here a computational study for estimating the permeability coefficient of a benchmark peptide by considering and comparing two different physical models: on the one hand, the inhomogeneous solubility-diffusion model, which requires umbrella-sampling simulations, and on the other hand, a chemical kinetics model which necessitates multiple unconstrained simulations. Notably, we assessed the accuracy of the two approaches in relation to their computational cost.
Pandey B, Thapa S, Biradar M, Singh B, Ghale J, Kharel P PLoS One. 2024; 19(12):e0309797.
PMID: 39739862 PMC: 11687663. DOI: 10.1371/journal.pone.0309797.
Pires C, Moreno M Membranes (Basel). 2024; 14(7).
PMID: 39057665 PMC: 11278619. DOI: 10.3390/membranes14070157.
Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume II.
Kutner A, Brown G, Kallay E Int J Mol Sci. 2023; 24(6).
PMID: 36982694 PMC: 10053869. DOI: 10.3390/ijms24065621.